There are 3162 resources available
1164P - The influence of neoadjuvant radiotherapy on surgical management and prognostic outcomes in locally advanced rectal neuroendocrine carcinoma
Presenter: Weiran Xu
Session: Poster session 17
1165P - The significance and indications for lymphadenectomy in pancreatic neuroendocrine neoplasms
Presenter: Yosuke Uematsu
Session: Poster session 17
1166P - 21-day modified CAPTEM protocol is effective and safe for patients with advanced well-differentiated grade 1/2 pancreatic neuroendocrine tumors
Presenter: Nomi Bezalel Engelberg
Session: Poster session 17
1167P - Outcomes of local and systemic treatment in primary hepatic neuroendocrine neoplasms (PHNEN)
Presenter: Leonidas Apostolidis
Session: Poster session 17
1169P - Clustering of patients with lung neuroendocrine neoplasms using machine learning and its association with survival: A population based study from the U.S. SEER database
Presenter: Mohamed Mortagy
Session: Poster session 17
1170P - Convergent and divergent determinants of heterogeneity, biomarkers, and plasticity in thoracic and prostate neuroendocrine tumors
Presenter: Triparna Sen
Session: Poster session 17
Resources:
Abstract
1403P - A phase II study of tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: Long-term follow-up outcomes of TD-NICE
Presenter: Tao Jiang
Session: Poster session 17
1404P - Predictive role of circulating cytokines in esophageal squamous cell carcinoma receiving chemoradiotherapy combined with anti-PD1 inhibitor: Pooled analyses of two phase II clinical trials
Presenter: Baoqing Chen
Session: Poster session 17
1405P - Long-term survival and post-hoc analysis of toripalimab plus definitive chemoradiotherapy for esophageal squamous cell carcinoma (EC-CRT-001 phase II trial)
Presenter: Ruixi Wang
Session: Poster session 17
Resources:
Abstract